AU4701593A - Oral pharmaceutical compositions comprising reduced glutathion - Google Patents

Oral pharmaceutical compositions comprising reduced glutathion

Info

Publication number
AU4701593A
AU4701593A AU47015/93A AU4701593A AU4701593A AU 4701593 A AU4701593 A AU 4701593A AU 47015/93 A AU47015/93 A AU 47015/93A AU 4701593 A AU4701593 A AU 4701593A AU 4701593 A AU4701593 A AU 4701593A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
oral pharmaceutical
reduced glutathion
glutathion
reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47015/93A
Inventor
Ferdinando Ventra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esseti Sas Laboratorio Chimico Farmaco Biologico Di A Ievoli & C
Original Assignee
ESSETI CHIMICO FARMACO BIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ESSETI CHIMICO FARMACO BIO filed Critical ESSETI CHIMICO FARMACO BIO
Publication of AU4701593A publication Critical patent/AU4701593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
AU47015/93A 1993-07-22 1993-07-22 Oral pharmaceutical compositions comprising reduced glutathion Abandoned AU4701593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1993/001947 WO1995003063A1 (en) 1993-07-22 1993-07-22 Oral pharmaceutical compositions comprising reduced glutathion

Publications (1)

Publication Number Publication Date
AU4701593A true AU4701593A (en) 1995-02-20

Family

ID=8165746

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47015/93A Abandoned AU4701593A (en) 1993-07-22 1993-07-22 Oral pharmaceutical compositions comprising reduced glutathion

Country Status (2)

Country Link
AU (1) AU4701593A (en)
WO (1) WO1995003063A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998029101A1 (en) 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
WO1999038507A1 (en) * 1998-01-30 1999-08-05 David George Le Couteur Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
SE9904132D0 (en) * 1999-11-16 1999-11-16 Sbl Vaccin Ab Pharmaceutical composition for treatment of diarrhea
IT1317856B1 (en) * 2000-02-25 2003-07-15 A C R Applied Coating Res S A ORAL GEL CONTAINING SULFURATED AMINO ACID COMPOUNDS.
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
EP2280697A1 (en) 2008-04-30 2011-02-09 Wockhardt Research Centre Oral liquid compositions of rhein or diacerein
JP6983664B2 (en) * 2016-01-29 2021-12-17 株式会社カネカ Peptide-containing compositions and peptide stabilizers, stabilization and storage methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
JP2792862B2 (en) * 1988-07-30 1998-09-03 寛治 高田 Oral enteric formulation
US5204114A (en) * 1992-03-30 1993-04-20 Health Maintenance Programs, Inc. Methods of manufacturing high dosage glutathione the tablets and capsules produced thereby

Also Published As

Publication number Publication date
WO1995003063A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
AU5804194A (en) Oral compositions
AU7842794A (en) Oral compositions
AU6216296A (en) Pharmaceutical compositions
GB9317686D0 (en) Pharmaceutical compositions
AU3716193A (en) Pharmaceutical compositions
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU6776494A (en) Oral compositions
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
GB9317610D0 (en) Pharmaceutical compositions
AU5274096A (en) Pharmaceutical compositions
AU2531295A (en) Pharmaceutical composition
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU7345094A (en) Oral compositions
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
AU2392492A (en) Pharmaceutical composition
AU4701593A (en) Oral pharmaceutical compositions comprising reduced glutathion
GB9317504D0 (en) Pharmaceutical compositions
AU7228294A (en) Oral care compositions
AU7073794A (en) Oral effervescent compositions
AU5512694A (en) Oral composition
AU3710695A (en) Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
AU2537992A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions